
### [NCIT:C7134](http://purl.obolibrary.org/obo/NCIT_C7134)
**Label:** Bone Surface (Peripheral) Osteosarcoma

**Subclasses:** [NCIT:C8969](http://purl.obolibrary.org/obo/NCIT_C8969) (Parosteal Osteosarcoma), [NCIT:C6589](http://purl.obolibrary.org/obo/NCIT_C6589) (Childhood Parosteal Osteosarcoma), [NCIT:C123398](http://purl.obolibrary.org/obo/NCIT_C123398) (Childhood Periosteal Osteosarcoma), [NCIT:C53958](http://purl.obolibrary.org/obo/NCIT_C53958) (High Grade Surface Osteosarcoma), [NCIT:C8970](http://purl.obolibrary.org/obo/NCIT_C8970) (Periosteal Osteosarcoma), 

**Class expressions from DL-Learner:**

- [UBERON:4200230](http://purl.obolibrary.org/obo/UBERON_4200230) (surface of bone@en) 62.50%
- Thing 52.03%
- [UBERON:0010199](http://purl.obolibrary.org/obo/UBERON_0010199) (bona-fide anatomical boundary) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 47.86%
- [UBERON:0006984](http://purl.obolibrary.org/obo/UBERON_0006984) (anatomical surface) and (not ([NCIT:C38997](http://purl.obolibrary.org/obo/NCIT_C38997) (Cancer Susceptibility Pathway))) 47.86%


